Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Other Non-Current Assets (2023 - 2025)

Beta Bionics (BBNX) has disclosed Other Non-Current Assets for 3 consecutive years, with $180000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 80.0% to $180000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $180000.0 through Dec 2025, up 80.0% year-over-year, with the annual reading at $180000.0 for FY2025, 80.0% up from the prior year.
  • Other Non-Current Assets hit $180000.0 in Q4 2025 for Beta Bionics, down from $183000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $183000.0 in Q3 2025 to a low of $100000.0 in Q4 2023.
  • Historically, Other Non-Current Assets has averaged $118111.1 across 3 years, with a median of $100000.0 in 2023.
  • Biggest five-year swings in Other Non-Current Assets: changed 0.0% in 2024 and later skyrocketed 83.0% in 2025.
  • Year by year, Other Non-Current Assets stood at $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then soared by 80.0% to $180000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for BBNX at $180000.0 in Q4 2025, $183000.0 in Q3 2025, and $100000.0 in Q2 2025.